- recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The MOMENTUM Study is tracking how a new type of advanced radiotherapy, called MR-Linac, works for people with different cancers. It aims to see if this treatment improves survival, controls cancer better, and enhances quality of life by using highly precise radiation guidance.
United States · Australia · Belgium - recruitingNA
Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends
This study looks at a special liquid food given through a tube to people who need extra nutrition. We want to see how well people tolerate it and if they like it. It's for children and adults with conditions like Cerebral Palsy or cancer who need tube feeding.
United Kingdom - recruitingNA
A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent
This study looks at a new type of tube, called a stent, for people with kidney stones or cancer that affects their bladder tubes. The new stent aims to reduce pain and infections, making life better for patients and potentially reducing hospital visits.
United Kingdom - recruiting
Value of Analysing Under-utilised Leftover Tissue (VauLT)
This study looks at how we can get a better picture of a patient's cancer by blending leftover tumour tissue from surgery. This helps scientists understand the cancer more fully, potentially leading to better diagnoses and treatments.
United Kingdom - not yet recruitingNA
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
This study looks at whether checking and treating dental problems before chemotherapy for blood cancers can reduce side effects like mouth sores and infections. It aims to see if this dental care plan, called PRIOR, is safe and can work in hospitals.
United Kingdom - ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase 1/2 Open-label Study of BMS-986466 in Combination with Adagrasib with or without Cetuximab in Participants with KRAS G12C-mutant Advanced Solid Tumors
This study is testing new combinations of medicines for advanced cancers that have a specific genetic change called KRAS G12C. It's looking at how safe the new medicines are and if they can shrink tumours in people with lung or bowel cancer.
Spain · Finland · France - ongoing, recruitingTherapeutic exploratory (Phase II)
Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO)
This study is testing if cannabis extract can improve the quality of life for cancer patients receiving palliative care. It compares the cannabis extract to a placebo to see if it helps with symptoms and overall well-being over approximately 12 days.
Germany - ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
TEMPLE - Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy
This study is testing new ways to treat cancer. It combines standard cancer drugs with newer immunotherapy to see if they work better together. Researchers are also looking for the best dose and how safe this new treatment is.
Denmark - recruiting
Understanding immunE-related toXicities by multifACeT Profiling
This study looks at side effects of a type of cancer treatment called immunotherapy. Researchers will collect blood and stool samples from patients to understand why these side effects happen, helping to improve care for people with cancer.
United Kingdom - active not recruiting
Comprehensive Segmental Revision System
This study looks at how well a special shoulder and elbow replacement system works for people with joint problems, arthritis, or after surgery for cancer or injuries. It will track patients for at least 10 years to understand their long-term outcomes and improve future treatments.
Canada · Denmark · United Kingdom